Dallas、TXにおける心不全の臨床試験
Dallasとその周辺地域（約30マイル以内）の拠点で、心不全に関する42件の研究が参加者を募集しています。研究を開いて、参加資格と連絡方法を確認してください。
公式研究テキスト（英語）
ここで研究参加者を募集していますか？ このページの上部に表示できます — 30日間 $99 →
ELEVATE-HFpEF Clinical Study
被験者募集中
- Dallas VA Medical Center, Dallas
Study to Evaluate the Effect of Balcinrenone/Dapagliflozin in Patients With Heart Failure and Impaired Kidney Function
被験者募集中第3相
- Research Site, Dallas
- Research Site, Dallas
- Research Site, Dallas
A Study to Test Whether Vicadrostat (BI 690517) in Combination With Empagliflozin Helps People With Heart Failure and a Weak Pumping Function of the Left Side of the Heart
被験者募集中第3相
- Texas Health Research and Education Institute, Dallas
- Southwest Family Medicine Associates, Dallas
A Study to Test Whether Vicadrostat in Combination With Empagliflozin Helps People With Heart Failure
被験者募集中第3相
- Texas Health Research and Education Institute, Dallas
- Southwest Family Medicine Associates, Dallas
- University of Texas Southwestern Medical Center, Dallas
A Research Study Comparing Different Doses of CDR132L With Placebo on the Structure and Function of the Heart in People With Heart Failure With Preserved Ejection Fraction and Left Ventricular Hypertrophy
被験者募集中第2相
- University of Texas Southwestern Medical Center, Dallas
NT-ProBNP-based Heart Failure Screening and Prevention Trial in Patients With Type 2 Diabetes: STRONG-DM Study
被験者募集中
- University of Texas Southwestern Medical Center, Dallas
- Parkland Health & Hospital System (PHHS), Dallas
- Baylor Scott and White - Health System, Dallas
A Study to Investigate CV Outcomes With Elecoglipron Compared With Placebo in Adult Participants With HFpEF or HFmrEF
被験者募集中第3相
- Research Site, Dallas
Study With Omecamtiv Mecarbil (CK-1827452) to Treat Chronic Heart Failure With Severely Reduced Ejection Fraction
被験者募集中第3相
- Baylor University Medical Center, Dallas
- The University of Texas Southwestern Medical Center, Dallas
Evaluation of Liver Stiffness Performance, by FibroScan®, to Detect Elevated Central Venous Pressure (CVP)
被験者募集中
- University of Texas Southwestern Medical Center - Clinical Heart and Vascular Center - West Campus Building 3 Location, Dallas
Maridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity
被験者募集中第3相
- Cedar Health Research, LLC, Dallas
Phase III Study Investigating Heart Failure and Cardiovascular Death With Baxdrostat in Combination With Dapagliflozin
被験者募集中第3相
- Research Site, Dallas
A Study to Determine the Efficacy and Safety of Finerenone on Morbidity and Mortality Among Hospitalized Heart Failure Patients
被験者募集中第3相
- Dallas, TX Investigative Site 10042, Dallas
Investigation of the BrioVAD System for the Treatment of Left Ventricular Heart Failure
被験者募集中
- Baylor University Medical Center, part of Baylor Scott & White Health, Dallas
- UT southwestern Medical Center, Dallas
A Study of EDG-15400 in Adults With Heart Failure With Preserved Ejection Fraction (EQUINOX-HFpEF)
被験者募集中第2相
- Local Institution - 167, Dallas
Efficacy, Safety, and Pharmacokinetics of Vericiguat in Pediatric Participants With Heart Failure Due to Left Ventricular Systolic Dysfunction (MK-1242-036)
被験者募集中第2/3相
- Children's Health-The Heart Center ( Site 0015), Dallas
AMBER-HFpEF: Assessment of CK-4021586 in a Multi-Center, Blinded Evaluation of Safety and Tolerability Results in HFpEF
被験者募集中第2相
- University of Texas Southwestern Medical Center, Dallas, Dallas
Product Performance Report: Evaluate Long-term Reliability & Performance of Medtronic Marketed Cardiac Therapy Products
被験者募集中観察研究
- Dallas, Dallas
A Prospective Registry Study to Assess Real-world Patient Characteristics, Treatment Patterns, and Longitudinal Outcomes in Patients Receiving Mavacamten and Other Treatments for Symptomatic Obstructive Hypertrophic Cardiomyopathy (Obstructive-HCM)
被験者募集中観察研究
- North Texas Cardiology Center, Dallas
- Baylor Scott & White Research Institute, Dallas
LEVEL-2: LEVosimendan to Improve Exercise Limitation in Patients With PH-HFpEF-2
被験者募集中第3相
- Tenax Investigational Site, Dallas
A Research Study to Look at How Well NNC0487-0111 Works Compared to Placebo in People With Heart Failure and Obesity
被験者募集中第3相
- Renal Disease Research Institute, Dallas
- Texas Health Heart and Vascular Specialists, Dallas
- Southwest Family Medicine_Dallas, Dallas
- 他1件
CSP #2025 - Geriatric OUt-of-hospital Randomized MEal Trial in Heart Failure: Veterans Affairs (GOURMET-VA)
被験者募集中
- VA North Texas Health Care System Dallas VA Medical Center, Dallas, TX, Dallas
OPtimal Adult Heart Transplant Immunosuppression With MicroRNA Levels
被験者募集中観察研究
- Baylor University Medical Center, Dallas
Multicenter Trial of ECMO in Children With Severe Cardiac Failure Using the Cardiohelp System
被験者募集中第2相
- Children's Health Dallas, Dallas
Assessment of CCM in HF With Higher Ejection Fraction
被験者募集中
- Baylor Scott and White Research Institute, Dallas
A Study to Learn More About How Safe Finerenone is, When it is Taken for a Longer Time With Standard Treatment, in Children and Young Adults With Heart Failure and Left Ventricular Systolic Dysfunction
被験者募集中第3相
- Children's Medical Center Dallas - Cardiology, Dallas
PROACTIVE-HF-2 Trial Heart Failure NYHA Class II and III
被験者募集中
- Medical City Healthcare Dallas, Dallas
- Baylor Scott & White -Dallas, Dallas
A Study to Learn More About How Well Finerenone Works, How Safe it is, and How it Moves Into, Through, and Out of the Body Compared to Placebo When Taken With Standard Treatment in Children With Heart Failure and Left Ventricular Systolic Dysfunction
被験者募集中第3相
- Children's Medical Center Dallas - Cardiology, Dallas
Trial to Evaluate Safety And Effectiveness of Mechanical Circulatory Support in Patients With Advancing Heart Failure
被験者募集中
- Baylor University Hospital, Dallas
Home-based Cardiac Rehabilitation in Heart Failure
被験者募集中第3相
- University of Texas Southwestern Medical Center, Dallas
- Baylor Scott and White Health System, Dallas
IEEM-Heat and Heart Failure
被験者募集中健康なボランティア歓迎
- Institute for Exercise and Environmental Medicine - Texas Health Presbyterian Hospital Dallas, Dallas
Using Ultromics EchoGo HFpEF Algorithm to Identify and Treat High Heart Failure Risk in Patients With Type 2 Diabetes
被験者募集中
- UT Southwestern Medical Center, Dallas
Sotagliflozin to Slow Kidney Function Decline in Persons With Type 1 Diabetes and Diabetic Kidney Disease
被験者募集中第3相
- University of Texas Southwestern, Dallas
XVIVO Heart Box (XHB) With Supplemented XVIVO Heart Solution (SXHS) Continued Access Protocol (CAP)
被験者募集中
- University of Texas Southwestern Medical Center, Dallas
Efficacy of LoDoCo in Improving Exercise Capacity Among Patients With HFpEF and Inflammation
被験者募集中第2相
- UT Southwestern Medical Center, Dallas
Cardiopulmonary Stress Testing (CPET) AlloSure Study
被験者募集中観察研究
- Baylor Scott & White health research institute, Dallas
Transplant of Redeemed Organs by Judicious Administration of New Direct-Acting Antivirals for Hepatitis-C Heart Recipients
被験者募集中第2相
- Baylor University Medical Center, Dallas
Remote Ischemic Preconditioning for Renal and Cardiac Protection in Congestive Heart Failure (RICH) Trial
被験者募集中第2/3相
- VA North Texas Health Care System Dallas VA Medical Center, Dallas, TX, Dallas
Cardiogenic Shock Working Group Registry
被験者募集中観察研究
- Baylor Scott & White Advanced Heart Failure Clinic, Dallas
Get With The Guidelines-Heart Failure Registry
被験者募集中観察研究健康なボランティア歓迎
- Amy Bennett, Dallas
Identification of Genomic Predictors of Adverse Events After Cardiac Surgery
被験者募集中観察研究
- UT Southwestern Medical Center, Dallas
Modulation of SERCA2a of Intra-myocytic Calcium Trafficking in Heart Failure With Reduced Ejection Fraction
被験者募集中第1/2相
- University of Texas Southwestern Medical Center, Dallas
他の都市における心不全の試験
- New York City, NY51件の研究
- Boston, MA44件の研究
- Houston, TX36件の研究
- Cleveland, OH33件の研究
- Chicago, IL31件の研究
- Philadelphia, PA31件の研究
- San Francisco, CA29件の研究
- St. Louis, MO26件の研究
- Durham, NC26件の研究
- Kansas City, MO25件の研究
- Atlanta, GA25件の研究
- Baltimore, MD24件の研究
Dallasにおける他の研究
- 乳がん55件の研究
- 非小細胞肺癌52件の研究
- 転移性癌42件の研究
- がん（全種類）37件の研究
- 前立腺がん36件の研究
- 大腸癌33件の研究
- 肥満症30件の研究
- 卵巣がん28件の研究
- 膀胱癌27件の研究
- 肺がん27件の研究
- 子宮内膜がん24件の研究
- 心血管疾患23件の研究
ClinicalTrials.govより、2026/10/05時点のデータを取得。各研究には独自の参加資格があり、参加可否は研究チームが決定します。